These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 2828667)

  • 1. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses.
    Donahue PR; Hoover EA; Beltz GA; Riedel N; Hirsch VM; Overbaugh J; Mullins JI
    J Virol; 1988 Mar; 62(3):722-31. PubMed ID: 2828667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombination between feline leukemia virus subgroup B or C and endogenous env elements alters the in vitro biological activities of the viruses.
    Pandey R; Ghosh AK; Kumar DV; Bachman BA; Shibata D; Roy-Burman P
    J Virol; 1991 Dec; 65(12):6495-508. PubMed ID: 1658356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes.
    Rigby MA; Rojko JL; Stewart MA; Kociba GJ; Cheney CM; Rezanka LJ; Mathes LE; Hartke JR; Jarrett O; Neil JC
    J Gen Virol; 1992 Nov; 73 ( Pt 11)():2839-47. PubMed ID: 1331290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma.
    Riedel N; Hoover EA; Gasper PW; Nicolson MO; Mullins JI
    J Virol; 1986 Oct; 60(1):242-50. PubMed ID: 3018287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective endogenous proviruses are expressed in feline lymphoid cells: evidence for a role in natural resistance to subgroup B feline leukemia viruses.
    McDougall AS; Terry A; Tzavaras T; Cheney C; Rojko J; Neil JC
    J Virol; 1994 Apr; 68(4):2151-60. PubMed ID: 8138999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FeLV-FAIDS-induced immunodeficiency syndrome in cats.
    Mullins JI; Hoover EA; Overbaugh J; Quackenbush SL; Donahue PR; Poss ML
    Vet Immunol Immunopathol; 1989 May; 21(1):25-37. PubMed ID: 2549691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and pathogenicity of individual variants within an immunodeficiency disease-inducing isolate of FeLV.
    Overbaugh J; Hoover EA; Mullins JI; Burns DP; Rudensey L; Quackenbush SL; Stallard V; Donahue PR
    Virology; 1992 Jun; 188(2):558-69. PubMed ID: 1316674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique long terminal repeat and surface glycoprotein gene sequences of feline leukemia virus as determinants of disease outcome.
    Chandhasin C; Coan PN; Pandrea I; Grant CK; Lobelle-Rich PA; Puetter A; Levy LS
    J Virol; 2005 May; 79(9):5278-87. PubMed ID: 15827142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and significance of delayed processing of the feline leukemia virus FeLV-FAIDS envelope glycoprotein.
    Poss ML; Quackenbush SL; Mullins JI; Hoover EA
    J Virol; 1990 Sep; 64(9):4338-45. PubMed ID: 2166820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenicity induced by feline leukemia virus, Rickard strain, subgroup A plasmid DNA (pFRA).
    Chen H; Bechtel MK; Shi Y; Phipps A; Mathes LE; Hayes KA; Roy-Burman P
    J Virol; 1998 Sep; 72(9):7048-56. PubMed ID: 9696797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic diversity in the feline leukemia virus gag gene.
    Kawamura M; Watanabe S; Odahara Y; Nakagawa S; Endo Y; Tsujimoto H; Nishigaki K
    Virus Res; 2015 Jun; 204():74-81. PubMed ID: 25892717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evolution of a novel, syncytium-inducing and cytopathic feline leukemia virus variant.
    Rohn JL; Moser MS; Gwynn SR; Baldwin DN; Overbaugh J
    J Virol; 1998 Apr; 72(4):2686-96. PubMed ID: 9525586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feline Leukemia Virus (FeLV) Endogenous and Exogenous Recombination Events Result in Multiple FeLV-B Subtypes during Natural Infection.
    Erbeck K; Gagne RB; Kraberger S; Chiu ES; Roelke-Parker M; VandeWoude S
    J Virol; 2021 Aug; 95(18):e0035321. PubMed ID: 34232703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum.
    Chandhasin C; Coan PN; Levy LS
    J Virol; 2005 Feb; 79(3):1351-60. PubMed ID: 15650161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Folate Carrier: an Entry Receptor for a Novel Feline Leukemia Virus Variant.
    Miyake A; Kawasaki J; Ngo H; Makundi I; Muto Y; Khan AH; Smith DJ; Nishigaki K
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning and characterization of a defective recombinant feline leukaemia virus associated with myeloid leukaemia.
    Tzavaras T; Stewart M; McDougall A; Fulton R; Testa N; Onions DE; Neil JC
    J Gen Virol; 1990 Feb; 71 ( Pt 2)():343-54. PubMed ID: 2155287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of a novel subgroup B feline leukemia virus from a cat infected with FeLV-A.
    Boomer S; Gasper P; Whalen LR; Overbaugh J
    Virology; 1994 Nov; 204(2):805-10. PubMed ID: 7941350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses.
    Stewart MA; Warnock M; Wheeler A; Wilkie N; Mullins JI; Onions DE; Neil JC
    J Virol; 1986 Jun; 58(3):825-34. PubMed ID: 3009890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feline leukemia virus subgroup C phenotype evolves through distinct alterations near the N terminus of the envelope surface glycoprotein.
    Brojatsch J; Kristal BS; Viglianti GA; Khiroya R; Hoover EA; Mullins JI
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8457-61. PubMed ID: 1326757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The surface glycoprotein of feline leukemia virus isolate FeLV-945 is a determinant of altered pathogenesis in the presence or absence of the unique viral long terminal repeat.
    Bolin LL; Ahmad S; Lobelle-Rich PA; Ooms TG; Alvarez-Hernandez X; Didier PJ; Levy LS
    J Virol; 2013 Oct; 87(19):10874-83. PubMed ID: 23903838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.